Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of nicotinic acetylcholine receptor modulators. It plays a role in creating compounds that target neurological disorders such as depression, anxiety, and cognitive impairments. Its structure supports binding selectivity to specific receptor subtypes, enhancing the efficacy and safety of resulting drugs. Commonly employed in research settings for structure-activity relationship studies aimed at optimizing central nervous system therapeutics.